Pacific Edge (Pacific Edge) Equity-to-Asset : 0.84 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pacific Edge's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $33.23 Mil. Pacific Edge's Total Assets for the quarter that ended in Mar. 2024 was $39.81 Mil. Therefore, Pacific Edge's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.84.

The historical rank and industry rank for Pacific Edge's Equity-to-Asset or its related term are showing as below:

PFGTF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75 Med: 0.85 Max: 0.94
Current: 0.84

During the past 13 years, the highest Equity to Asset Ratio of Pacific Edge was 0.94. The lowest was 0.75. And the median was 0.85.

PFGTF's Equity-to-Asset is ranked better than
87.98% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.59 vs PFGTF: 0.84

Pacific Edge Equity-to-Asset Historical Data

The historical data trend for Pacific Edge's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Equity-to-Asset Chart

Pacific Edge Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Equity-to-Asset

Get a 7-Day Free Trial

0.75

0.81

0.94

0.91

0.84

Pacific Edge Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial															0.94	0.93	0.91	0.90	0.84

Competitive Comparison of Pacific Edge's Equity-to-Asset

For the Diagnostics & Research subindustry, Pacific Edge's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Edge's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Equity-to-Asset falls into.

Pacific Edge Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pacific Edge's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	33.225	/	39.81
	=	0.83

Pacific Edge's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	33.225	/	39.81
	=	0.83

Pacific Edge (OTCPK:PFGTF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Pacific Edge Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Edge (Pacific Edge) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

PEB:New Zealand PEB:Australia

Address

87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016

Website

https://www.pacificedgedx.com

Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.